Raised 2022 full-year guidance on free cash flow(1), now expected to be greater than $515 million for the year vs greater than $50 million, based on stronger working capital performance and increased interest
/PRNewswire/ The "Middle East Respiratory Syndrome coronavirus S Protein Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule.
/PRNewswire/ The "Human SARS coronavirus Spike Glycoprotein Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key.
/PRNewswire/ The "Human SARS Coronavirus 2 RNA Dependent RNA Polymerase Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule.